Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The closing price of Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA) was $15.26 for the day, down -2.43% from the previous closing price of $15.64. In other words, the price has decreased by -$2.43 from its previous closing price. On the day, 0.51 million shares were traded. CNTA stock price reached its highest trading level at $15.46 during the session, while it also had its lowest trading level at $14.66.
Ratios:
Our analysis of CNTA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 21.52 and its Current Ratio is at 21.52. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.17.
On September 20, 2024, Morgan Stanley Upgraded its rating to Overweight which previously was Equal-Weight and also upped its target price recommendation from $11 to $26.
On September 19, 2024, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $33.B. Riley Securities initiated its Buy rating on September 19, 2024, with a $33 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 26 ’24 when Weinhoff Gregory M sold 10,000 shares for $17.04 per share. The transaction valued at 170,399 led to the insider holds 183,266 shares of the business.
Weinhoff Gregory M bought 10,000 shares of CNTA for $168,000 on Dec 26 ’24. On Dec 20 ’24, another insider, SAHA SAURABH, who serves as the Chief Executive Officer of the company, sold 55,000 shares for $17.44 each. As a result, the insider received 959,057 and left with 520,661 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNTA now has a Market Capitalization of 2062068480 and an Enterprise Value of 1331285504. For the stock, the TTM Price-to-Sale (P/S) ratio is 290.76 while its Price-to-Book (P/B) ratio in mrq is 4.03. Its current Enterprise Value per Revenue stands at 194.263 whereas that against EBITDA is -8.254.
Stock Price History:
The Beta on a monthly basis for CNTA is 1.55, which has changed by 1.1424658 over the last 52 weeks, in comparison to a change of 0.22263205 over the same period for the S&P500. Over the past 52 weeks, CNTA has reached a high of $18.97, while it has fallen to a 52-week low of $6.65. The 50-Day Moving Average of the stock is -9.43%, while the 200-Day Moving Average is calculated to be 18.31%.
Shares Statistics:
CNTA traded an average of 546.09K shares per day over the past three months and 518270 shares per day over the past ten days. A total of 131.66M shares are outstanding, with a floating share count of 90.14M. Insiders hold about 31.53% of the company’s shares, while institutions hold 51.06% stake in the company. Shares short for CNTA as of 1734048000 were 3633001 with a Short Ratio of 6.65, compared to 1731628800 on 2438816. Therefore, it implies a Short% of Shares Outstanding of 3633001 and a Short% of Float of 3.3800002000000005.
